Rankings
▼
Calendar
XOMAP Q3 2024 Earnings — XOMA Corporation Revenue & Financial Results | Market Cap Arena
XOMAP
XOMA Corporation
$311M
Q3 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$7M
+767.1% YoY
Gross Profit
$7M
100.0% margin
Operating Income
-$16M
-217.3% margin
Net Income
-$17M
-239.6% margin
EPS (Diluted)
$-1.59
QoQ Revenue Growth
-35.1%
Cash Flow
Operating Cash Flow
-$9M
Free Cash Flow
-$9M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$223M
Total Liabilities
$139M
Stockholders' Equity
$85M
Cash & Equivalents
$142M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$7M
$830,000
+767.1%
Gross Profit
$7M
$805,000
+794.0%
Operating Income
-$16M
-$6M
-170.3%
Net Income
-$17M
-$6M
-213.0%
← FY 2024
All Quarters
Q4 2024 →